A novel phycobiliprotein alleviates allergic airway inflammation by modulating immune responses.

RATIONALE it has been claimed that phycocyanin exhibits pharmaceutical functions in inhibiting histamine release and leukotriene biosynthesis. In allergic asthma, these inflammatory mediators are crucial for disease progression. OBJECTIVES the aim of this study was to evaluate the therapeutic potential of R-phycocyanin (R-PC) against allergic airway… (More)